Form D · Pharmaceuticals
Homology Medicines, Inc.
Bedford, MA · CIK 0001661998
Offering snapshot reported Aug 10, 2017 · SEC filing
- Reported sold
- $83.5M Offering amount: $83.5M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 28, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2017 | Initial | $83,500,008 | No comparison | 19 | SEC filing |
| Feb 16, 2017 | Amendment | $43,568,874 | $20,499,998vs Jan 6, 2016 | 7 | SEC filing |
| Jan 6, 2016 | Initial | $23,068,876 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-292496
Source: Form D, filed Aug 10, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Gillis | Director |
| Richard Gregory | Director |
| Kush Parmar | Director |
| Siyamak Rasty | Executive |
| Albert Seymour | Executive |
| Mahendra Shah | Director |
| Brad Smith | Executive |
| Paul Stone | Director, Executive |
| Arthur Tzianabos | Director, Executive |
| Cameron Wheeler | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
45 Wiggins Ave.
Bedford, MA, 01730
Bedford, MA, 01730